ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000260.1|Prodigiosin_1 # 2 # 553 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	BGC0000260.1|Prodigiosin_1 	2	553	+	Loose	2000	25.0238	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	36.73	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GCAGACGCTCACAATATCTACAGCAAAGAAGTGAATAACCCCGGACCTGACGGCGTTTGGTTCACCCAGGATGATTTGCTGGCCAGTCACGCCAAAAGCGAAAATGACGAGAACGGCAATTTCAGCCGCTGGATCAATTACAGCTCTACGGGCCCCGACAGGGAGCCTTTCACCGATGACGACCTGATTAACGAGTACTATACCTCCACCACCAGCGCCGACCGGGAAAGCATCGAAGAAGCCGGCTTCCGTGCGCCGGGAGCGGATGGTGTCTGGTTTACCGAAGACGATACGCCAACCACTTTGTCCAGACGTTGGGAGCGGCAGGATGAGGAAACTCAGCGTAGCCTGAGCGCGACCTACAATACACAAACCGCCGCCACCGTGGGGGAAATTAACGACGACGCCATTACTTACTACAGCGTCAGCGAATCGCAGGCGGGGTACTACATGGACGCCAGCTACCAGTCCCCTGGCGCGGACGGACAGTGGCTCACCGCAGATGATACGCCGGCGACCATGACGCTGAACTACGCCGATCCACGCGAGTAA	ADAHNIYSKEVNNPGPDGVWFTQDDLLASHAKSENDENGNFSRWINYSSTGPDREPFTDDDLINEYYTSTTSADRESIEEAGFRAPGADGVWFTEDDTPTTLSRRWERQDEETQRSLSATYNTQTAATVGEINDDAITYYSVSESQAGYYMDASYQSPGADGQWLTADDTPATMTLNYADPRE	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	15.43	gnl|BL_ORD_ID|4719|hsp_num:0	2914			1533	1680	rifampin
BGC0000260.1|Prodigiosin_2 # 854 # 1723 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.571	BGC0000260.1|Prodigiosin_2 	854	1723	+	Loose	1900	25.7942	TriC	32.5	3003681	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTCGCGGTTCCTTAATCGCCATGATAACGCCATTCATCAACGGCCAAGTGGATGAAAAGGCCCTTGCCGGTCTTGTCGACTGGCAAATCAAACATGGCGCTCACGGCCTGGTCCCGGTGGGCACGACAGGCGAATCTCCCACCTTGACGGAAGAGGAACACAAACGGGTGGTGGCCCTGGTGGCGGAGCAAGCGCAGGGACGAGTCCCGGTCATCGCCGGAGCCGGCTCCAATAATCCCGTAGAGGCGGTGCGTTACGCCCAGCACGCGCAACAGGCGGGAGCGGACGCGGTGCTCTGCGTCGCAGGCTATTACAATCGTCCCTCTCAGGAAGGGCTGTACCAGCATTTCAAAATGGTCCACGACGCGATAGATATTCCCATCATTGTCTACAACATCCCTCCCCGCGCGGTGGTGGACATCAAGCCTGAAACCATGGCGCGGCTGGCGGCGTTGCCGCGCATCGTCGGGGTGAAAGACGCCACTACGGATCTGGCCCGCATCAGTCGCGAACGCATGTTGATCAATAAGCCCTTCAGCTTTCTCTCCGGCGACGATATGACCGCCATCGCTTATAACGCCAGTGGGGGGCAAGGCTGTATCTCCGTTTCCGCCAATATAGCGCCGGCCCTGTACGGTCAAATGCAAACCGCCACTCTGCAAGGCGACTTCCGCGAAGCCCTGCGTATTCACGACTTGCTGGCGCCTCTGCACGAAGCGTTATTTCGCGAACCCAGCCCTGCGGGAGCCAAGTACGCCGCTTCGTTGTTAGGTCTTTGCAACGAAGAATGCCGCTTACCCATCGTTCCGTTAAGTGAGCAAACAAAATCAGATATCAAGAATATAATCAATGAGTTATACAGATAG	MFRGSLIAMITPFINGQVDEKALAGLVDWQIKHGAHGLVPVGTTGESPTLTEEEHKRVVALVAEQAQGRVPVIAGAGSNNPVEAVRYAQHAQQAGADAVLCVAGYYNRPSQEGLYQHFKMVHDAIDIPIIVYNIPPRAVVDIKPETMARLAALPRIVGVKDATTDLARISRERMLINKPFSFLSGDDMTAIAYNASGGQGCISVSANIAPALYGQMQTATLQGDFREALRIHDLLAPLHEALFREPSPAGAKYAASLLGLCNEECRLPIVPLSEQTKSDIKNIINELYR	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	28.47	gnl|BL_ORD_ID|2004|hsp_num:0	2194			258	375	triclosan
BGC0000260.1|Prodigiosin_3 # 2109 # 3257 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.601	BGC0000260.1|Prodigiosin_3 	2109	3257	+	Loose	700	26.5646	cmlv	33.93	3002700	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol phosphotransferase	ATGGACTTTCGACTCGATGATGAGCAGCTCGCTCGTGTCTCCCACGTGCGGGAATTCGCTCAACAAGTACTTTCGGAGTCGGCCCGGCGACGTATTGCAGAATCCGCGTTTGATCGCGAACTCTGGAACCGGGCTGCGGATTTGGGGCTGTCCGGGCTCCCTATCCCCGAGCAATGGAGCGGCTCCGGTTTCGGCGCCCTGGACACCATGCTGACAGTGGAAGCCCTCGGTTTCGGCTGCACGGACATGGGACTTGTCTTCTCACTCTGCGCGCACATGTTCGCCTGCGCAGTTCCTATCTGGCGTTACGGCGACGATACGCAACGCCAACGCTACTTACATCGCATATCCAAGGGCGAGCTGATCGCCGCCAACGCCATCACCGAACCGGAATCCGGCTCAGACGCTTTCGCCATGCGAGCCAGCGCTGTCCGGGACGGCGACACTTACATCCTGCGCGGAGAAAAGTGCTTCGTCACCAATGCGCCGGTGGCCGACCTGTTCCTGATATACGCCAAGACTGACCCCAGTCAGAGCTTTTTCGGCGTCAGCGGCTTCCTGGTTCCCCGGGACACCCCAGGGCTTTCCGTTACCGATGGCGGCTCCAAAACCGGCTTGTGCACCAGTCCATGGGGCTCGTTGTACATGGACGACTGTCGCATCCCTGCTTCCGCCTTACTGGGTGAAGAAGGCGGTGGCGCGCCGATGTTCCATGACTCTATGATCTGGGAGCGCGGCTGTCTGTTCGCCGCCTATGTCGGCGCCATGGAGCGCGTGTTGCAACAAAGCATCGACCACGCCCGCAACAGAAAGCAGTTCGGCCAGTCCATCGGCCGCAATCAGTCTATTTCGGACCGGCTGGTGGATATGAAGTTGCGCCTGGAAACCTCCCGACTCCTGCTGTATCGGGCTGGCTGGCTATACGACCAGGGCGAACCTTACGAGGAAGCCATCGCCCTCAGCAAACTCTGGATCTCCGAATGTTCCGTGCTAAGCGGGCTGGACGCCATGCAGGTCTTTGGCGGCACGGGGGTTTCCAGCGCCGCCGGCGTTGACCGGCTGCTTCTGGATTCACTGCCATCGAGAATATTCTCGGGGACCTCTGAGATTCAGAAAGAGCTGATAGCCAGACATATGGGATTGCGCTGA	MDFRLDDEQLARVSHVREFAQQVLSESARRRIAESAFDRELWNRAADLGLSGLPIPEQWSGSGFGALDTMLTVEALGFGCTDMGLVFSLCAHMFACAVPIWRYGDDTQRQRYLHRISKGELIAANAITEPESGSDAFAMRASAVRDGDTYILRGEKCFVTNAPVADLFLIYAKTDPSQSFFGVSGFLVPRDTPGLSVTDGGSKTGLCTSPWGSLYMDDCRIPASALLGEEGGGAPMFHDSMIWERGCLFAAYVGAMERVLQQSIDHARNRKQFGQSIGRNQSISDRLVDMKLRLETSRLLLYRAGWLYDQGEPYEEAIALSKLWISECSVLSGLDAMQVFGGTGVSSAAGVDRLLLDSLPSRIFSGTSEIQKELIARHMGLR	MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC	87.61	gnl|BL_ORD_ID|649|hsp_num:0	703			489	642	chloramphenicol
BGC0000260.1|Prodigiosin_5 # 3490 # 3903 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.543	BGC0000260.1|Prodigiosin_5 	3490	3903	+	Loose	190	23.0978	Escherichia coli emrE	33.33	3004039	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	ATGAAAATAGTGAAGATTCTCAGATACTTATTCGGCGCCCTCTATGTCATGGCGGGCGTCGCCAAGGCGTTTCCGCAAATTGAAGATGTCGGCGTCACGCTGCAAAAAGCCGCCGCCGCCAACCAGGGAACCTGGCTGGCCGGTCTCAGCGAGTGGCTGGCGGGTAATGCGCAACTGATGGCTTGGATCAGCGGCATTGCGCTACTCGCATCCGGTCTCTGTTATTTATTCAATCGCATGCTGATTCCCGCTGTCATCGGCCAATGCGTCATGCTGGCGGGCTTCGTCACCATACTCCACCGGGCGTTTCCACAGATTGTGTTCGTGGATTTGATCTTTCTGATTGTCGCCCTGCTTGTCCTGTGGGAATCCGTCAATCAGAAGAAATCTCTGTACGCCCTGCCCCACTATTAA	MKIVKILRYLFGALYVMAGVAKAFPQIEDVGVTLQKAAAANQGTWLAGLSEWLAGNAQLMAWISGIALLASGLCYLFNRMLIPAVIGQCVMLAGFVTILHRAFPQIVFVDLIFLIVALLVLWESVNQKKSLYALPHY	MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLIINLLSRSTPH	124.55	gnl|BL_ORD_ID|2317|hsp_num:0	2656			210	330	erythromycin
BGC0000260.1|Prodigiosin_6 # 4012 # 5709 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.582	BGC0000260.1|Prodigiosin_6 	4012	5709	+	Loose	600	28.8758	Streptomyces venezuelae rox	51.61	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGAATCACAAGACAACTCACAGTATGCAGGCGAAGCGCCTGTATTCCCCAGCAAAGACTTTGAATGCAATCAAGGCTCCTTTGACGACACGGACACCTCTCCCCCGCAACACGCCGGCGATTATGACGTTATTGTCGTCGGCGGCGGCATATCCGGACTGTCTTCCGCCTGGAAGCTGCGCGAGCGCAAGCTATTGGTGCTGGATCAACGGGATCGCTTCGGCGGCGCGGCGCGTCTGGAACAGCGGGATGGCCTGTTATACGCCAGCGGCGCCTCCTGCTTTCAGTTGCCCACCGGCCACAACGAAGTCTCTCACCTGCTGCAGGATCTGGACCTGTGGAACCAATGGCGCTCCACTGCGGAAGACACTCTGGTCATCTTTGACACCAAACGTCTGATGAAAGGTTTGGGGGAAGTCACCGCCGCCTTGTTGAAACAACCCAAAGAATTACTGAAGCCTGCAGTCTGGGGACTGACCGCCAATCTGCTGTACAGCGCCATGTCCGGCAAACCGTTCATCTCCGCGGAGAAGAAGCTGGGCGATCCCATGTTCGCCGACTTATTCCAATATCTTAATCGATTCACTCCTGATTCCGGCAAACACCCCGCCATGCCTTGGCGGGAAGGCTGCGACTGGACGCGGGAGGAGATGGAGTTGTTCGATTCCGTTTCTCTGCATGATTTGCTGTTCGACCCGGCCACGCGACGCTCCCTGCCGCAGGACCTGATTCCCAGACACCGCTTTGGTTCATTAGTGAAAGACGCCGTGGAAACCACGCTGCGCGTAGAGTGCCTTGCCATCAAAGATGTCTCCGCCTACGTCGGCCTGCATTTCCTGGTGGGATATCTTTATCGTCCTCTGGTCACCTTTCCCGGCGGCAACGGCTACATCGCGGACCGCATACGTCAGCGTCTGATGAGCACAGGTTCCTGTAAGTTCAAGGCAGGTTCCCGGGCCTATTCCATCACTCAGAATCAGGAAGGCGTAAAAGTCTGTTTCCAGCAGGAAGGCAAAAATTATTACGCCAACGCCAATGCGCTGATCTGGGCCGGAGCCAAACACGCCGCCGTGTCAGTGGTGGATGGCTTACCACAACAGCAAAAAGCCGCCATCGCAGAAATTGAACACCGGGATTACGCCATCGCCGGGGTGTACCTGAAAAAAGCGGCGCTGGCCAATTACTTCGGCGGCTACGTCATCGAAGGCGATATCGGCGGCCGCTACCCCAATAGCTGGTGCCGCAGCGGCGTCTGCCTGGCGGCGAACTGGAAAGACCCGTCCTACGCCGGCGGCCTCGGCGTACTCACTCTGCTGAAGCCCATTTCCGGCGCCGCAGACCAGGGCAAATTGGGCAAAGCCGACTTCCGCAATCTGCAGCAAACCGCCTACGGTGAGGTACGCGACATGCTGGTCGCCACCGGCCACTCCCCCGACCTGATTGAAGACATCAAATTATGGCGCTGGCCCCATGGTCTGGTGGTATCCAAAGTAGGCCAAATGAAACATGACGTGTTCGTCAACGCCTCTCAGCCCGTCGGCGCAGTGTTCTTCGCCAATCAGGACAGCGTCGGCATGGGCAATATGGAAAGCGCCATCTGGGCGGGCTGTCACGCCGCGGAACAGGTGCGTCGACACTTCCGCTCCCACAGCAGCGTCGTCTCCCATATCGGCGACTACGCAGCGACCCAGAGCTAG	MESQDNSQYAGEAPVFPSKDFECNQGSFDDTDTSPPQHAGDYDVIVVGGGISGLSSAWKLRERKLLVLDQRDRFGGAARLEQRDGLLYASGASCFQLPTGHNEVSHLLQDLDLWNQWRSTAEDTLVIFDTKRLMKGLGEVTAALLKQPKELLKPAVWGLTANLLYSAMSGKPFISAEKKLGDPMFADLFQYLNRFTPDSGKHPAMPWREGCDWTREEMELFDSVSLHDLLFDPATRRSLPQDLIPRHRFGSLVKDAVETTLRVECLAIKDVSAYVGLHFLVGYLYRPLVTFPGGNGYIADRIRQRLMSTGSCKFKAGSRAYSITQNQEGVKVCFQQEGKNYYANANALIWAGAKHAAVSVVDGLPQQQKAAIAEIEHRDYAIAGVYLKKAALANYFGGYVIEGDIGGRYPNSWCRSGVCLAANWKDPSYAGGLGVLTLLKPISGAADQGKLGKADFRNLQQTAYGEVRDMLVATGHSPDLIEDIKLWRWPHGLVVSKVGQMKHDVFVNASQPVGAVFFANQDSVGMGNMESAIWAGCHAAEQVRRHFRSHSSVVSHIGDYAATQS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	118.70	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	96	rifampin; rifaximin; rifapentine
BGC0000260.1|Prodigiosin_7 # 5736 # 8462 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.594	BGC0000260.1|Prodigiosin_7 	5736	8462	+	Loose	1500	255.373	rphA	27.94	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACATACGATTCGCATATTGTTGAAGTCTCCGGACAACAGAACTCCAACGCGCAGAGCCTGGGAGGCAAAGCCAGCTCGCTGAATACGCTGGCGGCGGCGGGGTTCCCCGTACCCAGGGCGTATTGTCTGACCGTGGACGCTTACGCCTCCTTCCTGCGCGAGTCAGGACTGGACCAATGGATCAGCGGTCTGGATCAACAGGACGCCAGCGCCTTTACGCAAATCCGCCAGCGTATTGAGGAAACGCAACTGCCCTCCTCGTTGCGTCAGGCGATCATCGGCGCGTACAAGGACATCGGGGCGGAACGCGTCGCCGTGCGCTCCTCCGCCATCAGCGAGGACAGCGAAGAACACTCCTTTGCAGGCCAGTACGACACCTATCTGCATGTAGAAAACGAAGAAACGCTGGTGGACTGCGTAAAGCGCTGCTGGGGGTCTTTCTGGACAGAGCGCGCGCACGCTTACGAAGGCCGTCAGGATCAACGCCGCCGCAGCAGCGACGCCGACGCCCCCATGCAAGGCATCGCCGTGGTGATTCAGGCCATGATCGATGCAGACGCCGCCGGCGTATTGTTCACCGCCGATCCCCTGAACGGCGACCCGCAACGCACGGTGATCGAATCCTGTTGGGGGCTGGGCGAAGGCGTCGTATCGGGCCAGGTGACGACCGACACTTTCGTCATCGACAATCAGAAAATGGAGCTGCTGGAGCAAACCCTGCGGGAAAAACCGCTGATGTCCACCCGCGCGGAGAACGGCGGCGTCTGCCTGCGAAAAACTGCAGAAAATAAAATCCGCGCCCCCACCCTCAACGAAAATGAAGCTCTGGCCCTGGCGGGCTACGCCAACGCCATTCGCAGTCATTATGGACGGGAGATGGATATTGAGTGGGCGCTGAAGGACGGTAAGATCTGGATTCTGCAGGCGCGCCCCATCACCGTCACGCCAACCAACAGCGACAACCGGCTGTTTGCGGACGCAGATGAGAGCAACAGCTACATACGCGATAACGCACTGTTCTCGCGTATGGATACCGGCGAGATCGTCACCGGACTGATGACGCCGCTGGGGCTGTCGTTCTGCCGCTTCTACCAGCACAACGTACATGGCCCCGCAATCAAAACCATGGGGTTACTGGATATCGGCGATTCTCAGCATTACATGGGATATCTGCAGGGACATGTGTATCTCAACATTTCCGCATCAGCGATGTTGCTGACCCAATGCCCGCCAACCCGGGATGCATTGAAGTTCACCAAACGTTACTCTACGGAGGAAGTGGACCTGAACTTCTACACCAACCCCTACGGCAAAGCGCCGCAAGGACTGCAGTATCTCAAGAGCGCGGGCTACTGGACGCTGTATCAGGTGCGCAATCTTGTGACTGCGGAACGCACCGTGCGCGACATGATCTCATTGCGCAAGCGAGAGACCGAACGCTTCCTGAAGCTGGATCTCAGCGCCATGTCGCTGGGCGAGCTGAATGCGGAACTGCAACGCATCGACCGCTATTTCCTGGAATCCTGCGCCGCCTACATGCCGTTTTTTCTACAGTCATTCGCACTGTATGACGCCCTCGCGGAGTTATGTGAGAAGTGGCTCGGCGACACTGGCAAAGGGTTACAGAATCGCATCAAAGCGTCTCTCAGCAACCTGCGCACCATCGAAGTGACGCGCGGCGTCTGTGATCTGGCGGCCTCCGTCCAACGTTCAAGCCACTTGCGCCAACTGGTTCTGGAGACGCCTTTGGAGCAATTGGCGCAGGCGCTGCAGAACGACGACGAAGGCGCGCGCTTCTGGAACAATGATTTCATGGCGTTCCTGCGCGACTATGGCGCCCGCGGGCGTCAGGAGTTTGAACTCAGCATACCCCGTTGGGCCGACGACCCCAGTTATCTGCTGCAGGTGATTCGTATGTACCTGACCAGCGACGTGCAGTTGGAGTCGCGGCTGGAAGAGATCGATCGCAAACGGGACGACGACACCCGCGCCTTGCTGTCCGGCCTGCCCTTGCGCATTCGTCTGTTGTTCAAGTTCGTCATCTCCACCTACGCCAAAATGGCGGAGCGACGCGAAGCCACCCGGCCCACTTATATCGCGCAAACCTGGTTCTACCGCAAAATCATCGTCGAAGTCATGCGCCGCCTCAGTGCGGAGAAAGTGCTGAAAATGGAGGACTTGCCTTACATCGACTTCAACGAGCTGCGCGACTATGTGGCGGGAAGAAAATCCGCGCAACAGGCTTTCTCCGCAGAACTGATTGAGCGTAACCGACGCAGTCACTTGCTGAACCAGCGTCTGCAGGAACCGCCCATGGCGATTGTCGGCGGACATGAACCCCGCCGGGAAACCGCGGAAACAACGCCCACAGATGACAACCAGGTGTTCCAGGGCATCGGCGCCAGTCCCGGCGTCGCCATGGGCCGCGCCCGCGTGATCACCGATCTGCCGCGGCAGGCGGAGGAGTTTCAGCAAGGCGAGATACTGGTGGCCCGTTTCACCGACGCCTCCTGGACGCCGCTGTTCGTGCTCGCCGCCGGGGTTGTCGCCGACGTGGGGTCGATGTTATCGCACAGCTCCATCGTGTCCCGGGAGTTCGGCATCCCCGCCATCGTCAACACCAAAACCACCACTCGCCGCATCCGCACCGGAGATATGCTCTATCTCGACGGAGACGCAGGCGTCGTACGCATAGAAGAACGCAAGGAGGACGCCAGTCAGTAG	MTYDSHIVEVSGQQNSNAQSLGGKASSLNTLAAAGFPVPRAYCLTVDAYASFLRESGLDQWISGLDQQDASAFTQIRQRIEETQLPSSLRQAIIGAYKDIGAERVAVRSSAISEDSEEHSFAGQYDTYLHVENEETLVDCVKRCWGSFWTERAHAYEGRQDQRRRSSDADAPMQGIAVVIQAMIDADAAGVLFTADPLNGDPQRTVIESCWGLGEGVVSGQVTTDTFVIDNQKMELLEQTLREKPLMSTRAENGGVCLRKTAENKIRAPTLNENEALALAGYANAIRSHYGREMDIEWALKDGKIWILQARPITVTPTNSDNRLFADADESNSYIRDNALFSRMDTGEIVTGLMTPLGLSFCRFYQHNVHGPAIKTMGLLDIGDSQHYMGYLQGHVYLNISASAMLLTQCPPTRDALKFTKRYSTEEVDLNFYTNPYGKAPQGLQYLKSAGYWTLYQVRNLVTAERTVRDMISLRKRETERFLKLDLSAMSLGELNAELQRIDRYFLESCAAYMPFFLQSFALYDALAELCEKWLGDTGKGLQNRIKASLSNLRTIEVTRGVCDLAASVQRSSHLRQLVLETPLEQLAQALQNDDEGARFWNNDFMAFLRDYGARGRQEFELSIPRWADDPSYLLQVIRMYLTSDVQLESRLEEIDRKRDDDTRALLSGLPLRIRLLFKFVISTYAKMAERREATRPTYIAQTWFYRKIIVEVMRRLSAEKVLKMEDLPYIDFNELRDYVAGRKSAQQAFSAELIERNRRSHLLNQRLQEPPMAIVGGHEPRRETAETTPTDDNQVFQGIGASPGVAMGRARVITDLPRQAEEFQQGEILVARFTDASWTPLFVLAAGVVADVGSMLSHSSIVSREFGIPAIVNTKTTTRRIRTGDMLYLDGDAGVVRIEERKEDASQ	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	104.97	gnl|BL_ORD_ID|890|hsp_num:0	910			15	2589	rifampin; rifaximin; rifabutin; rifapentine
BGC0000260.1|Prodigiosin_9 # 11184 # 13724 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.613	BGC0000260.1|Prodigiosin_9 	11184	13724	+	Loose	700	26.5646	PDC-241	26.05	3006619	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGAAATTCGGATTTATCGGACACCCGACCTCCATCGGGCTGAAACGCTACGTAAAAATGCTCGACTTGCTCGACCGCAGTTCGCGAGACCTGCAAGTGGGCTATCAGCGGGACATATGGAGTCATCGTAATCTGGTGCCCTTCGTCGATTTCGGCCGTATTCAGTCCCCCGCAGGAGTCAGCTGCGAAGGCATCGTGCATTACCTTCCGCTCACCGCAGAGGAAATGCTGTCCACCCCCAGGGCGGTGCAACAGCGTATTTTTGAAGGGATAGAGTCGTTGCAGGCGCAGGGCGCTCAGCTCGTAGGCCTGGGCGGCTTTACCTCGATTATCGGCAAGCGCGGGCTGGTGACGGCGGAGCGCGCCGGCATCCCCGTGACCAGCGGCAACTCGCTCACCACTTACGCGGGCTACACCGTGCTGCTGCAGACGCTGGAGCGTTTACAGCTCGATCCGGCGGATGCGCAGGTGGCGATAGTGGGTTATCCCGGCTCCATCTGTCTGGCGCTGGCCAAGCTGTTGCTACAGCTGGGCTGCCGCCTGGATTTGGTTCACCGGGGCACGGCGGATGATGCGCAACTGCTGGAGCACCTGCCTGAGCATTGGCGCAGTCGGGTCACCTTGTTAAATTCCATGGACGCGGCGTATGAGCGCAATCGCCTGTTCGCCGCCGCCACCTCGTCCGGCGGCGTAATCGACGTATCCCGCCTGGCGCCCGGCTCCATTGTCGTAGACATCGCCCTGCCTCGCGACGCGGAGCGCCCTCCTACGCCCCGTACTGACGTACTGGTGCTGGACGGTGGCTGCGTTACCGCTTCGCCGGCGACCAAGCTGGGCGGCGAGTCCATGAACATGTCCATCAAACAGCAGATCAACGGTTGTCTGGCGGAAACCATGGTGCTGGCTCTGGAGGGTCGCGCGGAGTGCTTCTCCATTGGTCGCGACCTGCCCCCGGAAAAAGTGCTGGAGATAGGAGAAATCGCAGAGCGTCATGGCTTCCGCGCCTTTCCTCTGGCGTCCTATGGCGAGCGCATCAACATCGAACTGATCAACGGGCTGCGTCGCTTCCACCATCGCGGTAACGCTCAGGCGCCAGGCTATACCCCATCGGATCTGGCGGCGACGGAGCCGGATTCCGGCGAAGCGCGACGCTCGCAAACCGTGCAGCGCTACCGCAGTTATATCAACCCCATGCTGGCGGATTTCCTGCAAATGCAGCGCTGTGACAAAGTCTTCGAACGCGCGGAAGGGTGCACCCTGACTGATACGGACGGCGAGCGTTTTCTCGACATGGTGTCCGGCTACGGCTGCCTCAATCTGGGCCATAACCCGCAAGTGGTGACGGAGGCGATCCAGAAGTACGTCGCCAACATGGGGCCCAACTTCGTGCAATACGTTTCCCTGCCGGAAGAGACCTCCAAGCTGGCGGAGCGGCTCTGCGCGGTGGCGCCGGGACGCTTCGAACGGGTTTTCTTCAGCAACTCCGGCACGGAAGCCGTGGAGGCGGCGCTGAAACTGGCGAAAGCGGCCAGCCGTCGCTCCCGTTTTGTCTTCGCCAATAACAGTTATCACGGCAAGACACTGGGCGCGCTCTCCGTCACCGGTCGCGAAAAGCATCAGAAGCATTTCCGCCCCCTGCTGCCGGGTTGCACGGGCGTGCCGTTCGGCGACCTGGAGGCGCTGCGCGTTGAGCTGGAACAAGGCGACGTGTGCGCATTCATCATTGAGCCGATCCAGGGAGAAGGCGGCGTCTATCTACCGCCGGACGGCTATCTGAAGGCTGCACAGGAACTGTGTCGGCGCACCGGAACCCTGCTGATCGTGGACGAAATCCAGACTGGCCTGGGGCGCACTGGACGCCTGTTCGCCTGCGAATGGGAAGGAGTGGAGCCTGACATTATGGTGTTGTCGAAATCCCTGTCCGGCGGGCTCATTCCCATCGGCGCAACGCTCAGTTCCGCGCAGATCTGGGACGCAGCCTACGCCTCCACCGGACGCTTCCTGTTGCATACCTCCACCTTCGGCGGCTGCAACTTGGCCGGCGTCGCCGGGCTCGCCGCGCTGGAAGGCGTAATAGAGCAGGATCTGCCGCGCCGTGCGCAAGAGATGGGCGACTATTTCAAAGCCGAACTGCAGCAAGCGGTGCAAGCCTACCCCTTTATCAAGGAGGTGCGCGGTCGTGGCCTGATGTTGGGCATTCAGTTCAACAACGACTTCAGCGGCGCCGTGGAAGCCTGCGCCCGGGAGTTCGGCACGCGTTTGCCGGGAGACTGGCATCTGGCGTACCGCTTTTTCCCTGACGAAGTGCGCGAGCACTTGGCGGCGGCGGTGGGCAAGATGGAGGAATCACTGGCGGAAATGTTCTGCATGCGCTTCGTCACCAAGCTCAGTAACGATCACCGCATTCTGACTTTCGTCACCGCCAACAGCTCAACCGTGATACGTATCCAACCCCCGCTGATCATCAGTAAAGAGGAGGTCGACCACTTCGTGAAATCCTTCGCCACCGTATGCGAAGAAATGTCCACTTTTATGAACTAA	MKFGFIGHPTSIGLKRYVKMLDLLDRSSRDLQVGYQRDIWSHRNLVPFVDFGRIQSPAGVSCEGIVHYLPLTAEEMLSTPRAVQQRIFEGIESLQAQGAQLVGLGGFTSIIGKRGLVTAERAGIPVTSGNSLTTYAGYTVLLQTLERLQLDPADAQVAIVGYPGSICLALAKLLLQLGCRLDLVHRGTADDAQLLEHLPEHWRSRVTLLNSMDAAYERNRLFAAATSSGGVIDVSRLAPGSIVVDIALPRDAERPPTPRTDVLVLDGGCVTASPATKLGGESMNMSIKQQINGCLAETMVLALEGRAECFSIGRDLPPEKVLEIGEIAERHGFRAFPLASYGERINIELINGLRRFHHRGNAQAPGYTPSDLAATEPDSGEARRSQTVQRYRSYINPMLADFLQMQRCDKVFERAEGCTLTDTDGERFLDMVSGYGCLNLGHNPQVVTEAIQKYVANMGPNFVQYVSLPEETSKLAERLCAVAPGRFERVFFSNSGTEAVEAALKLAKAASRRSRFVFANNSYHGKTLGALSVTGREKHQKHFRPLLPGCTGVPFGDLEALRVELEQGDVCAFIIEPIQGEGGVYLPPDGYLKAAQELCRRTGTLLIVDEIQTGLGRTGRLFACEWEGVEPDIMVLSKSLSGGLIPIGATLSSAQIWDAAYASTGRFLLHTSTFGGCNLAGVAGLAALEGVIEQDLPRRAQEMGDYFKAELQQAVQAYPFIKEVRGRGLMLGIQFNNDFSGAVEACAREFGTRLPGDWHLAYRFFPDEVREHLAAAVGKMEESLAEMFCMRFVTKLSNDHRILTFVTANSSTVIRIQPPLIISKEEVDHFVKSFATVCEEMSTFMN	MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQGKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPITLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	213.10	gnl|BL_ORD_ID|4309|hsp_num:0	5379			165	495	
BGC0000260.1|Prodigiosin_10 # 13757 # 14776 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.603	BGC0000260.1|Prodigiosin_10 	13757	14776	+	Loose	400	28.4906	erm(45)	19.35	3004595	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGAAATTAGCAAAGACCAGATTGTTGACCTGATGATGGGTTTCTTCAAAACCAAAACACTGACAGCCGCCTTCGACCTGGGGCTGTTCGACGCCATGGCGGAGGGCCCCGCCTCACTGGAGGACATCTGCGCCCGCGCCAATGCGCCGGTCGCGTCGGGCAAGCGCATGTTGATCGCCCTGCACGCGATGGGGTTGCTGCAACGCGAGGGAGACGCCTATTCCCTGGCTCCGGGCGCTGCGCCCTACTTGGTCAGCCAGTCTCCGCAATGGCTGGGATGGCTGGGCCGCCACATCGATGCGTTCCTGTATCCGCTGTGGTCCTACACCGCCCAGGCGGTGCGCGACGACAAAGATCAACGGGAGGCGGTGTTCGGCGACAAGCGCAGTTGGTTCGATATCCTGTATCAGAACCCTTCCGACGTGACGGACTTTCAGGAGTTCCTGGGTATCTTCGCCAAGCCCTTTATTGACGGTATGGTGGAAGGCGTGGACTTTTCCGCCTACAGCCGCTTCATGGACATTGGCAGCGGCGTCGGCAGTTTGCCCGTCGCCGTGGCGGAAGCCTGCCCACACCTGGAGATCGCCATCTGTGAATTGCCCAAAGCGGCCTGCTACGTGCGCGACAAAATCATGTCCGGCGAGTTCGCTGACCGCATTGATGTGGTCGAAGGCGATGTCATCGCCGGAACCATCCCACAGCAGGAGTACGACCTGATCCATCTGGGCTGGATGTTGCACGACTACGCCCCTGACACGCAGTTGCAGATTCTGCGCAACATTTACGACGCCCTGCCGGCAGGCGGCGTCTTCATGGCCAGTGAAACGCCCCTGGACGAAGACGAAAGCGGCCCCCTGTTCACCTCCCTGCTCTCCATCAACATGCTGGTGTCCACGGATGGCGGTGTGGAGTCCACGGCGCAGCAGTATATGCAGCGCTTTGAAGAGGCCGGGTTCAGCAACGTGAGAGTGCTGCGCATCAACGGACCGCGCACGTTATTCGTCGGAGAAAAAGTCTGA	MEISKDQIVDLMMGFFKTKTLTAAFDLGLFDAMAEGPASLEDICARANAPVASGKRMLIALHAMGLLQREGDAYSLAPGAAPYLVSQSPQWLGWLGRHIDAFLYPLWSYTAQAVRDDKDQREAVFGDKRSWFDILYQNPSDVTDFQEFLGIFAKPFIDGMVEGVDFSAYSRFMDIGSGVGSLPVAVAEACPHLEIAICELPKAACYVRDKIMSGEFADRIDVVEGDVIAGTIPQQEYDLIHLGWMLHDYAPDTQLQILRNIYDALPAGGVFMASETPLDEDESGPLFTSLLSINMLVSTDGGVESTAQQYMQRFEEAGFSNVRVLRINGPRTLFVGEKV	MNQNIKFTQNFITNEKLLSNIMKQINIDENDIIYEVGTGKGHLTSKLAEKCKHVYSIELDKKLYELSSNKLQDNSRVTLINQDILQFNYPYRKKYKIVGNIPFNISTQIVKDAVFRSQASEMYFIVEEGFYKRMIDTRRTLSLQLQTQVYIQQLLPIPAGSFHPKPKVNCILIKLTRHISDIKDKHKKKYEFFISKWVNKEYSKLFTKNQYHQALKHARIKDLNKISYEQVLSVFESYILFNPRK	138.37	gnl|BL_ORD_ID|4721|hsp_num:0	3296			33	294	erythromycin; clindamycin; pristinamycin IA
BGC0000260.1|Prodigiosin_12 # 15101 # 17314 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	BGC0000260.1|Prodigiosin_12 	15101	17314	+	Loose	550	27.335	IMI-7	33.33	3003177	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGACAGAACAAGTATTTGCCGATTCGCAACAGGCGGAAGCCTCCTTGCGGGAACTGGTGCTGAGCGCCTTGCAGCGTCACACGGAATACGCTCGAGAAGACTTTGACGACGACGCGGATTTCGAGGGCGACCTGGGCGTGGATTCCATCACCCTGGCTTCCGTGCAGGCGGAAATTTATCAGACGCTGGGGCTGCAGAATAAATCAGTACAGGCGGGCCTGGACAACGTTGGACAACTGCTGCGCCATATCGGTCAACGCCTGCAGAAAGAAGGCCTCAGCATCGCCACGGCTGCGCAGCAAACAGCGCCGGCCCGCCGCGCTGACGCACAGGACGACGCACTAAGCGCGAACGTGCTCGACGTGTATCAGGCTCACACTGGCTACCGTCGCAGCGAGCTGGATCTGCAAGCGGACCTGGAAGGCGATCTGGGCGTCGATTCCGTGACCCAGGCTTCCGTGCTGGCGGAGATCGCCAAGCTCATTCGCGTGGAGAAAACCGGATTTCCCGCCGGCCTGAGCACCATCGCGCAAGTCATCGCTTACCTGCGCGAGATCGGCGCCGACGCCGACCTGGCCCGTCCCGCCAAAGAAGTGGGCGCCGCCCCGGCCCCCCAAGCGGTTTCCAGACAACTCGCAGAAAGCCGTGGCGGTGGCATGTGGACGGATTTCATCGACCGCCTTAATCAGGATGAGGTCGCGGAGCCCAGTGACGCTGCGACGGAACTGGCGGACCAGTTCAAGCTGAGCTTCCTCGCCAGCGGTTTCGGGCAGAAGGACATCTCCGCTCTGCACGACCGTCTGCGCAGCGAGCACGGTATGCCCGCCCATCTGAATCTGGCGGACTGCGATACTCCCGAGAAACTGTTGCAATACATTAGAGCCAGCCGTCCGCATCAGGTTGAAGCGTTGGGAGTGGAACACCAGGATGCGGCCTACGGAGCCAGCGCCGCGGCGGAAAACGATCCCCGCACCATGAAAGATTTCGTCAATCTGCCGGATCGGGATCTGTTTCATAAGGCCCGGGAGTTCCGCAAGTTCTACGTGGCGAAGCAGCAGGCGCAGCTGTATTGGTACGGCATGCCTCTGGAATCCCAATGCCGTAACCGTGCGGTGATCTACGACGAAGTCACCGGACGCCGCCGTGAGTTTTTGATGTTCGCCTCCAACAATTATCTTGGACTGGCCAATCATCCCGAAGTCATTGAAGCCATCGCCGAAGGCGCCCGTCGCTACGGCGCCACCAATACCGGTTGCCGTCTGATCGGGGGCAGTAATGTCCTGCACAAGGAACTGGAGCGCCGTCTGGCCAAACTGAAAGGACGCGAAGCCTGCATCGTGTATCCGTCCGGCTATTCAGCCAACCTGGGCTGTATCTCGGCGCTGGCCGGACGCAACGATCTGGTGTTCACCGACTCCATCAACCACATGAGCATTCAGGACGGCTGCAAACTCTCCGGGGCTTCCCGCAAGATTTATCAGCACAGCATGGAAAGTCTGGAGAACACACTGAAAAAATACGCCGACCACGACGGCGGCAAACTGATCGTCACCGACGGCGTGTTCTCCATGCACGGCGATATCGTCGACCTGCCGCGTCTGGTGGAGCTGGCGCAGCAATACGGCGCCCGTGTACTGGTGGATGACGCCCACTCCACCGGCGTTCTCGGCAAAACCGGCTCGGGCACCACCGAACATTTCAACATGAAGGGTATGGCCGATCTGGAACTGGGCACCATGAGCAAGGCGCTGGCCGGCGTCGGCGGCTTCGTGTGTGCGGATGAGGAAGTGGTGGAGTACCTGCGCTTCTACTCCAACTCTTACGTGTTCGCCGCCACTATCCCCGCCGCCGTGGCGGCGGGCGTGATCGCCTCTATCGACGTGATGGAGCGCGAGCCGCAGCGCTTGAGCAAACTCTGGAGCAACATCCATCGTCTGCGCGGTCATCTGCTGGGCGCCGGGTTCGATTTGGAGCATTCCAACAGCGCCATTATTCCGGTGGTGGTGGGCGACGACCGCAAAACCCTGGAGCTCGGCCGCGCCGTCCGCGCTCGCGGCATGTACTGCCAGACCGTGGTGTTCCCCGGCGTGGCGGTGGGCGACGCGCGTCTGCGCATCAGCGTCACCAGCGAACACACCGAGGAGGACCTGGATATGGCGGCGCAGATCATCATCGACGCAGCAAAAGAAGTGAATATTCCCGTCACGCTGTGA	MTEQVFADSQQAEASLRELVLSALQRHTEYAREDFDDDADFEGDLGVDSITLASVQAEIYQTLGLQNKSVQAGLDNVGQLLRHIGQRLQKEGLSIATAAQQTAPARRADAQDDALSANVLDVYQAHTGYRRSELDLQADLEGDLGVDSVTQASVLAEIAKLIRVEKTGFPAGLSTIAQVIAYLREIGADADLARPAKEVGAAPAPQAVSRQLAESRGGGMWTDFIDRLNQDEVAEPSDAATELADQFKLSFLASGFGQKDISALHDRLRSEHGMPAHLNLADCDTPEKLLQYIRASRPHQVEALGVEHQDAAYGASAAAENDPRTMKDFVNLPDRDLFHKAREFRKFYVAKQQAQLYWYGMPLESQCRNRAVIYDEVTGRRREFLMFASNNYLGLANHPEVIEAIAEGARRYGATNTGCRLIGGSNVLHKELERRLAKLKGREACIVYPSGYSANLGCISALAGRNDLVFTDSINHMSIQDGCKLSGASRKIYQHSMESLENTLKKYADHDGGKLIVTDGVFSMHGDIVDLPRLVELAQQYGARVLVDDAHSTGVLGKTGSGTTEHFNMKGMADLELGTMSKALAGVGGFVCADEEVVEYLRFYSNSYVFAATIPAAVAAGVIASIDVMEREPQRLSKLWSNIHRLRGHLLGAGFDLEHSNSAIIPVVVGDDRKTLELGRAVRARGMYCQTVVFPGVAVGDARLRISVTSEHTEEDLDMAAQIIIDAAKEVNIPVTL	MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLEKDFNGRIGVYALDTGSGKSFSYKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDERDTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK	252.40	gnl|BL_ORD_ID|1024|hsp_num:0	1120			552	705	
BGC0000260.1|Prodigiosin_13 # 17402 # 19027 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.603	BGC0000260.1|Prodigiosin_13 	17402	19027	+	Loose	1000	160.614	almE	27.4	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAAAGCACAAGAAACGGAAAGCGGATTTGTTCCTGTCATCGACTATTTACGACGCTCCGCCGCCAATTTTCCCCAGCGCCCGGCGTTTGTCGGCCCGGAGGAAATAAGCTACGAGCAGTTCTACGCCAGAGTGCGCCGCTGGGCCGGATATTTCCGCTACGCCGGTCTGCAGCCCGGGGACCGCGTGGCCATCTGGTTGCCCAAGCAAATCGATTATGTGGTCGCCCTCTACGCCGCCATGGAATGCGGCGGCGTGTACGTTCCTATGGATGGCGTGCAGCCGGTGGAGCGGGCGAAAAAAATTCTCGCCGGCGCGGAGCCCGCCATTCTAGTTACCGACAGCGCCCGTTTTGAGCAACTGGATGATACGACTTGCGCGTCATTACGGCTGGCGCTGGTCACCGACTTCCACAAAGTTCCTGACGCGGCTGCGCCCGGCTGTTTCGCCGTTGCGTCACGGGCGTCGGCGGACGCATTCGAGCCAACGCCGGAGCAAACGCCGCATCATCCCGGTCCACAGGATCTGGCGGCGATTCTATTCACCTCCGGCTCCACCGGTATGCCCAAGGGCGTTCAGATCAGCTACGGCAACCTGCACGCCTTTATTGGCTGGGCGCTGCAAGAGCTTTCCCTGAGCGAACGGGACGTCTTTTCCAATCATGCCGGTTTCCATTTCGATCTCAGCACCTTCGACCTGTTCGCCGCAGCGGCGGCGGGCGCGGGGGTCTGGGTTATCGGCGAGGAACAACAACGGGATGTCGCCGCGCTGTCGGAGGGCATTCATCGCTATGGGATCAGCGTTTGGTACAGCGTTCCCTCCATCCTGTCCCTGATGGTGAACGCAGGCGCTCTGGATACCGACGTCACCGCCTCGTTGCGCTATCTGATATTCGCTGGCGAAGTCTTCCCGATTCGCCCCTTACGGGAGCTAAGCCAGCGTTTGCCAGCGGACTGTGCGCTCTATAACTTCTATGGGCCGACCGAAACCAATGTCTGCCTTTACTATCGGGTGACGGCGGAAGACCTGCAACGGGACAAGCCAGTGTATATCGGCGCTCCGCTGCCCGGGCAAACCGCCCTTGTGCTGGACGACCAGGGCCTGCCTGTCAGCGCTCCCGGCGCCATTGGCGAATTAGTCATCGAGGGCTCCTGCGTCACGCCGGGTTACCGCAACCGCGTCGACCCCGCCAACGCCGATAACCATCTACAGGGACGCCATGCGACCGGCGATCTGGTGGGCTACGAAAACGGCTATCTGTACTACCACGGGCGCAAGGACCGCATGCTGAAAATCAATGGCTACCGGGTGGAGTTAGGAGAGATCGAAGCGGCGTTGTCGACCATGCCGGGCATCCGGGAAATCGCCGTGGTGGCGGAAATCACCGAGCAGGCGCAAAACCTCATTGCCTATTTCAGTGCGGTTGATCCGGCCTCTGCGCCCAGTGTGCTCGCCATCAAGCAGCACTGTCAGACGCGGTTGCCCCGTTACATGATTCCCAAGCTGGTGCGCAGACTGGACGAACTGCCCAAAAGCCGTAACGGCAAAATTGATTATCTGGCGTTAAAAGCGTTGGCGTTCAAGCCGAATGTTACGCCACAGACTCACACAGACCCGGTTGCCTGA	MKAQETESGFVPVIDYLRRSAANFPQRPAFVGPEEISYEQFYARVRRWAGYFRYAGLQPGDRVAIWLPKQIDYVVALYAAMECGGVYVPMDGVQPVERAKKILAGAEPAILVTDSARFEQLDDTTCASLRLALVTDFHKVPDAAAPGCFAVASRASADAFEPTPEQTPHHPGPQDLAAILFTSGSTGMPKGVQISYGNLHAFIGWALQELSLSERDVFSNHAGFHFDLSTFDLFAAAAAGAGVWVIGEEQQRDVAALSEGIHRYGISVWYSVPSILSLMVNAGALDTDVTASLRYLIFAGEVFPIRPLRELSQRLPADCALYNFYGPTETNVCLYYRVTAEDLQRDKPVYIGAPLPGQTALVLDDQGLPVSAPGAIGELVIEGSCVTPGYRNRVDPANADNHLQGRHATGDLVGYENGYLYYHGRKDRMLKINGYRVELGEIEAALSTMPGIREIAVVAEITEQAQNLIAYFSAVDPASAPSVLAIKQHCQTRLPRYMIPKLVRRLDELPKSRNGKIDYLALKALAFKPNVTPQTHTDPVA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	97.30	gnl|BL_ORD_ID|4935|hsp_num:0	5928			147	1632	colistin A; colistin B
BGC0000260.1|Prodigiosin_14 # 19029 # 21857 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.633	BGC0000260.1|Prodigiosin_14 	19029	21857	+	Loose	350	28.8758	Alkalihalobacillus clausii chloramphenicol acetyltransferase	35.9	3004452	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGACTGACGCCAGCTTATTTTCTTCCGCCTCATCCAGTTCTCATGACCAGACGTTGCGCGAGCCTGTCGCCATCGTGGGCATCGCCTGCATTACGCCCTCCGCCCAGGATACGGAATCGTTCTGGCGATTGCTTGACCGCGGCGAGCGCGCGCCGCTACGGGCAATGCCTGCCCATCGAATACCGCAGACCAGCGCAGCGGCCAAGGCGCACTTAGACGCTTGGCGCGGTTCATTTTTTGCGGAGGCGGAGAGTGATTTCAAACGCTTTCGCATCCCTCCCGCTTACCGTAAATCCGTGTCCCAAATGATGCTGTTGCAGCTGCGCGCGGCGGAGCAATGTCTGCGTGACGCAGGCTATCCCGACAAGCTGCCGCCACTGGACGACACCGACGTATACAGCGGCGCCTGCTTTTGCTTCGACAGCGCGCTTAACAACGCCTTGAAAGTGGAAGGCGTGCGGCTCGCTTACGAGGCCGCGGAGCAACGCTCAGGAGACTGTGAAGCGGACCTGGACGCCATCCGCGAGCGACTGCGCGAGCATTTCGGCCTGTCATCCCATGATCGCGTCGGCGAAATGGCGAGCAGCATACCCGCCCGCATCGCCTCGCACTTTGGTTTTCGCGGCCGCGCCCAGGCGCTGGAGTCCGCCGACGCCACCAGTTACGTGGTGCTGGAGGCCGCCTTGCTGGCGTTGTCTGGAGGCCAGACCAAAGCGGCGCTGGTCATCGCCGGACAACGCTATGACAGCCTGCTGCCCGCGCTCGCCCTGGAGAAAAAAGGCTTCGCGTCCGGCGCGCCTTTCACCGCCAATTCTGCTGGAGCGCCGCTGGCGGAAGGCGCCACGGCGTTATTATTGAAGAAGCTAAGCGACGCCCGCCGGGACGGCGATTGCATCTACAGCGTCATTCGCGGCGCCGCCTGCGCCCGCCGGGACTCTCCCTCCGGCTACCGCTACGGCGGCGATGCGGCGCTGAAATATCAAGCCGCTGCGGAAGCCTGCCGTCAGGCCAATATCAGTCCCGCTAGACAGCGTTTCATTGAGTGCGCGTTGCCTGGCCATGCGGAAGAAAGCAAAGCGCTACTGACCGCGATGGCGGATTTACGCCATGACGATAGCGTCCCTCTACATCTGCGCTCCTGCGTCGCCAACCTGGGATACGCATTCGCCAACGCCGGACTCAACGCCATCGCCGCCGCCAGTCTGGCGTTGCGCTACGGTCGCCTGCCTGGCATGCCGCAAGAGGACGGTCAGGAATTATTACAACGTCAGAACATCGACTACGGCGCCAACGGCGGCGAGCCCTGGCCGCAAACGGATGAGCTTATCGCCGGCGTGTGCGGGGGCGGACTGAGCGGCGTCAGTTGGCATATGGTGCTGTCCAGCCCGGATGCGGTGGCGGCGGACGTGGAGACAGCTCCAGTCCCGCAGGAGCCCATCGCCATTGTCGGCGTCGGAGGCTCTTTCGGTCCTTGGCGCGACGTGACGGCAATACACGCAGGCCTGTGGGATGGCGCCGATGGAATTCAGCCAATACCGGAAGCGGTATTGCCCCATCGCGCCTTTTTCAGCGCGGATGCATCCCGACCGCTGAGTTGTTACGCGCAATATGGCGCAGCGTTGGCGCAAAGCGAATTCGACTTATCCCCCTATAAAATCTTTCCACGCCGGGCCGCCGGCATGGACAAGGCGCAAAAGCTGGGGCTGCAATGCGCCGCCGAGGCTCTGGCGGATTATGGGCTGTCGCGCAAACGTCAACGCCAGGGCGCCACGGCGGTGTTTATCGCCAGCAACCTGAACCTGGGACGGGAGCGCGCGCTATCCGCGGCGTTGCATTATCCCCAGCTACAGGCGCTGTTCGCCGGCTCCACGCTGGCAAGCTACTTTCAGGACGCCGTCGCAAAACAGCGGCTCTCCCCCGAGGAGGTCGATCACTTCACGTTCGACAGCTTTTCCGCCAGCGGCATCGCGGCGTTGATCTCCAATTGCTTTCAACTCAACGCCGCCCCAGCCGCCGTGGAAGCGGCCTGCGCTTCGTCTCTGGCGGCGCTGCATAACGCCGTGCTGGCGCTGCGCAGTCATCGCTACGACCTGGTGCTGGCGGGTGGCGTGGAGCTGCCGGTGAACATTCGCGACCTGACGCTGTGCTCCGCGCAAATGATGTTGTCACAGCACAAGATCGCGCCTTTCGCGGTAGACGCCGACGGGTTTTCACCCGGGGACGGCGCCGGCATGTTCGTCCTCAAGCGCCTGAGTGACGCACTGCGGGATGGAGATACTATTTACGCCGCCATCACCGGCGTCGGCGCCTCCTGCGACGCCCGCTCCATGACGGCGCCGGACCCACAGGGACAGGCGCTGGCCATGCGCAAAGCCTTCGTTCAGGCCGGTTATTCTCCTGCTCGCGTGCAGTACGTGGAAACCCATGGCACGGGCACCCGGTTGGGAGATATTGCGGAACTCTCCGCGTTGAATGAGGTTTATCTCGCGCCTGAACGGAGCGGTCCGCTAAAGGTGGGTTCGGTCAAATCCAATATCGGACACACCTTCGCCGCGGCTGGCTCAGCGGGCCTATTGAAAACCCTGCTGGCGATCCGTTACGGTGATATCCCGGCCACGCTGTTACGACGGGAGATGAACCCGGAGCTGCCCCTGGCGGAGATACCCACGGAGCCCGTCACCGCCCTGCAGCCCTGGCCACTGGGCGATGGCGCCCGTTACGCCGCGGTCAGCTCATTCGGCACCGGCGGCGTCAATTATCATCTGCTTTTGCAGTCCGTAACCGCTACCCATGCGGCGCCGGACGACTCTCAATACACTGCAAGTTAA	MTDASLFSSASSSSHDQTLREPVAIVGIACITPSAQDTESFWRLLDRGERAPLRAMPAHRIPQTSAAAKAHLDAWRGSFFAEAESDFKRFRIPPAYRKSVSQMMLLQLRAAEQCLRDAGYPDKLPPLDDTDVYSGACFCFDSALNNALKVEGVRLAYEAAEQRSGDCEADLDAIRERLREHFGLSSHDRVGEMASSIPARIASHFGFRGRAQALESADATSYVVLEAALLALSGGQTKAALVIAGQRYDSLLPALALEKKGFASGAPFTANSAGAPLAEGATALLLKKLSDARRDGDCIYSVIRGAACARRDSPSGYRYGGDAALKYQAAAEACRQANISPARQRFIECALPGHAEESKALLTAMADLRHDDSVPLHLRSCVANLGYAFANAGLNAIAAASLALRYGRLPGMPQEDGQELLQRQNIDYGANGGEPWPQTDELIAGVCGGGLSGVSWHMVLSSPDAVAADVETAPVPQEPIAIVGVGGSFGPWRDVTAIHAGLWDGADGIQPIPEAVLPHRAFFSADASRPLSCYAQYGAALAQSEFDLSPYKIFPRRAAGMDKAQKLGLQCAAEALADYGLSRKRQRQGATAVFIASNLNLGRERALSAALHYPQLQALFAGSTLASYFQDAVAKQRLSPEEVDHFTFDSFSASGIAALISNCFQLNAAPAAVEAACASSLAALHNAVLALRSHRYDLVLAGGVELPVNIRDLTLCSAQMMLSQHKIAPFAVDADGFSPGDGAGMFVLKRLSDALRDGDTIYAAITGVGASCDARSMTAPDPQGQALAMRKAFVQAGYSPARVQYVETHGTGTRLGDIAELSALNEVYLAPERSGPLKVGSVKSNIGHTFAAAGSAGLLKTLLAIRYGDIPATLLRREMNPELPLAEIPTEPVTALQPWPLGDGARYAAVSSFGTGGVNYHLLLQSVTATHAAPDDSQYTAS	MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVTKIVNAHREFRINFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYENDAERYNGTRRLFPKKPIPDNPIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDELFLPVSIQNASCLFVMATMQSVFINDLQNLVDESEDWIYLVVSDEWYY	413.16	gnl|BL_ORD_ID|4665|hsp_num:0	2891			402	504	chloramphenicol
BGC0000260.1|Prodigiosin_15 # 21872 # 22189 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.575	BGC0000260.1|Prodigiosin_15 	21872	22189	+	Loose	750	24.2534	patA	37.93	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAAACCATCATTCACAAAATCCGCCTGTTCGATGTCGCACAGGCCGACGCCTTCGAGTTCTGGGTGCAAAACGTCGATTACGCCACCTGCCCCGACCTGCCCAGCGTCGTGAGGTTTGACGTGCATCGCGCGTCTTTGCAGGCAAACGCCCCTTATCACTATGTGGAGGTGATAAAAATAACCGACCGCGCCGCCTTTGACGCCGACATGGAAACATCAACGTTCGCCGGATTGGTGCAGGCCTTTTCCCGTATGGCGGAAGTCGTTGAAGAATTGGCCGGCGAGCAGCTGGGCTCGGGCTATGCCGCAGGCTGA	METIIHKIRLFDVAQADAFEFWVQNVDYATCPDLPSVVRFDVHRASLQANAPYHYVEVIKITDRAAFDADMETSTFAGLVQAFSRMAEVVEELAGEQLGSGYAAG	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	18.62	gnl|BL_ORD_ID|1907|hsp_num:0	2081			609	696	ciprofloxacin; norfloxacin
BGC0000260.1|Prodigiosin_18 # 24271 # 24981 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.551	BGC0000260.1|Prodigiosin_18 	24271	24981	+	Loose	400	26.9498	DIM-1	20.41	3000848	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	DIM beta-lactamase	ATGATCATTGTGATCGAGGCCATGGCCGTCGCCGGCGTCATCGCCGCCTTGATCACCAAGGACACCAAGGCGCCCTTTATCTTTGGGTTTAATACGCTGTTGCCGGTAACGCTGGTGTATTGCTGGTACGGCGACGCGGACCTGGCGCGTAAGGCCCTGCTGTTGGGCATGGTGATTATTTACCAATTGCGCATGAATGTGGTGCTCACGCTTTGGTACAACAACACCGCCGCCGCCAAGCTCAAGGAAGTCATGCCGCTGTCGGCCATCTACTTTTTACCGATCATTCTCGCCAACGTATTTGGCTGGCTCTACTGCCTGCCGTTCCAGTGGGCGGCGGACCGGGTCGGGCCATTAAACTGGATCGATTACAGCGCTGTCGCCGTCTATTTGGTCGGCACTATTTTCCACTTCGGCAGTGATTATCAGAAACACTTATTCAAGCAACAACCCAACTCTCGCGGCCAGATTCTGGACACAGGCTTCTGGCGCTACTCCCGCCATCCCAACTATTTCGGCGACTTTTTGATTTACGTCTCCTTCGGCCTCACCGCCGGCAACCCCTGGGGCGTCATCGCACCCCTGGCCAATATCGCGCAGTACATGGCGGACGCCATTCCCAAAAGCGAAAAAATGGCGGAAGAACGCTACGGCGAAGCCTGGCGGAACTATAAGAAAAAGGCCAAATGCCTGATCCCGTTTGTGATCTAA	MIIVIEAMAVAGVIAALITKDTKAPFIFGFNTLLPVTLVYCWYGDADLARKALLLGMVIIYQLRMNVVLTLWYNNTAAAKLKEVMPLSAIYFLPIILANVFGWLYCLPFQWAADRVGPLNWIDYSAVAVYLVGTIFHFGSDYQKHLFKQQPNSRGQILDTGFWRYSRHPNYFGDFLIYVSFGLTAGNPWGVIAPLANIAQYMADAIPKSEKMAEERYGEAWRNYKKKAKCLIPFVI	MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKGNAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTSTNHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRSLDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNKSIQPNANASAD	94.02	gnl|BL_ORD_ID|1651|hsp_num:0	1718			240	387	
BGC0000260.1|Prodigiosin_19 # 25487 # 26104 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.608	BGC0000260.1|Prodigiosin_19 	25487	26104	+	Loose	2110	25.409	MexF	41.18	3000804	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAGATCAAGACGTTATTCGTCATCGATCGCCATAGTCACCTGGCGACGGAGCAAGCCGTTCCAGAATCCGCCTGGGTGTTGCAAGGCATGGGGCTCGCCACCGAGAAATTCGACGGCAGCGCCTGTCTGTTCAGAGCAGGCCGTTTGTGGAAACGTTACGACCGCAAACTGCGCAAGCCGTTCGCCGCGAAGCTCCGCGCCGGGCGTCTCGCAACTCTGGAGCACGCCATGTTCAAATCAGCCCCGGATGGATTTACTCCTTGCGAGGCGGAGCCTGACGCCATTACCGGTCACTGGCCCGGCTGGCTGCCGGTTTCCAAGGCCAGCCCGGAAGATCGCTGGCATTGCGAAGCCCTTGAACAGGCCGCCGACACACTGATCGAAGGCCAGACCTACGAGCTGGTCGGCCCGAAAGTTCAGGGTAACCGCTACCAGCTGCAGCGCCATGCGCTGTGGGCCCATGGCGGCAAGATCCTGACGCCGCCGGAGCGCCTGGACTTCCACTCTCTGCGCGACTGGATGGCGGCGCAAAGCATGGAAGGCGTCGTGTGGCATGCGCCGGATGGACGTATGGCCAAACTAAGGCGAAAAGATTTCGGTTTTTCATGGTGA	MKKIKTLFVIDRHSHLATEQAVPESAWVLQGMGLATEKFDGSACLFRAGRLWKRYDRKLRKPFAAKLRAGRLATLEHAMFKSAPDGFTPCEAEPDAITGHWPGWLPVSKASPEDRWHCEALEQAADTLIEGQTYELVGPKVQGNRYQLQRHALWAHGGKILTPPERLDFHSLRDWMAAQSMEGVVWHAPDGRMAKLRRKDFGFSW	MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA	19.30	gnl|BL_ORD_ID|2353|hsp_num:0	1300			1620	1722	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000260.1|Prodigiosin_20 # 26098 # 26301 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.417	BGC0000260.1|Prodigiosin_20 	26098	26301	+	Loose	550	21.557	SHV-165	50.0	3001203	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGGTGAATACTGGCCTGGGATTCTTCCCGGGCTTTTATTTTCCCCTCTCATCTCCCACTCTAATCACTATATCCGCCAGCCCGCAGCCACTAACTTTCGGTTTTAAAAACACTTTTTTATCCACGCTAAAAAAACATTATTACCCGGATAATATTGACTTCATTTTTTACCCCGGTATTATTGGCGGCGTATTTTCAGGATAG	MVNTGLGFFPGFYFPLSSPTLITISASPQPLTFGFKNTFLSTLKKHYYPDNIDFIFYPGIIGGVFSG	MRYIRLCIISLLAPLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	23.43	gnl|BL_ORD_ID|1861|hsp_num:0	2021			30	78	
BGC0000260.1|Prodigiosin_21 # 26343 # 26954 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.575	BGC0000260.1|Prodigiosin_21 	26343	26954	+	Loose	550	26.1794	KPC-4	34.78	3002314	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGAGCGTAAAAGAAACTCAGAGCTATACCGGCTTTCACGGCCACCAACTTTTCGCCGCCGGCGACTTGCCTGACGTGGCCTTAAAGGCCAAGGCTTTATTGGAGCAGGACACAAACGCCCCCGTCGCTATCTACGACAACGCGACCGGCAGGATCGTGGATATCGATTATCGCGGAACGGCTGAGGAGGTTATCGCCAGAATCGCAGCACGCAGCGAAGATGGAGCTCCCAAGCCTAAAGCCGGGCCTGGACGTCCCAAACTGGGAGTGGTGTCGCGTGAAGTCACGCTGCTGCCCCGGCACTGGGACTGGTTGAGAGCGCAACCCGGCGGCGCATCGGTGGCGCTGCGCAAACTGGTCGAAGCGGCCAGACGCGACAATGTGGATATCGACAAATCCCGCCTGGCGCTTGAAGCCGTGTATCGATTCATGTCCACCGTCGCCGGCGACTTCCCTGGTTTTGAAGAAGCCTGTCGCGCCTTCTTCGCCAAAGACTATGAGACGTTTGACGACATGATTTCGCTATGGCCTGACGATATTCAGGACCATATCCGGCATCAGACGGAGAACGCATTGCAAATGCAGAAAAAAGCGGAGGCTCAGCAGGACTGA	MSVKETQSYTGFHGHQLFAAGDLPDVALKAKALLEQDTNAPVAIYDNATGRIVDIDYRGTAEEVIARIAARSEDGAPKPKAGPGRPKLGVVSREVTLLPRHWDWLRAQPGGASVALRKLVEAARRDNVDIDKSRLALEAVYRFMSTVAGDFPGFEEACRAFFAKDYETFDDMISLWPDDIQDHIRHQTENALQMQKKAEAQQD	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	69.28	gnl|BL_ORD_ID|410|hsp_num:0	454			57	189	
BGC0000260.1|Prodigiosin_22 # 27021 # 27716 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.570	BGC0000260.1|Prodigiosin_22 	27021	27716	-	Loose	575	26.5646	ELM-1	29.81	3006885	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ELM beta-lactamase	ATGGCTGACAATTCTATCGTTCGCCTGGGGGCGACACTTATTCTTGCGGCGGCTTACGCGACTTCGGCGCAGGCGGCGGACTACTCTGTTGGCGGCATGTTGGGGACGCAGGGCGTTGGCGTCACCGCCGCCAAACGGACGGACTGGAGTCTGGTGGATGAGGATCAACTGCAGCTGCGATTCACCTTCGGCGGAATTGATGTGGATGACGTCGATGATCTTGAGCTGAGCGGAACCAAATACAAAGCGGATTTCCGCACCGGGACGCTGACGGGCGGTGTGGACTGGTATCCGTTCTCCGGTAAGTATGTGGATAACATCTTCTTTTCCGGCGGTCTGGTTTATTTTGATCACGATATCAAGGGGACGACCAAGTCAGGGCAGTCTTTCAACGTCGGCGGCGCACACGTCAGCAGTAGCGATAATGTGCGTCTGGATGCGGAAATCGATCAGTCCTCCTGGGCGCCTTATCTGAGCCTGGGGTGGGGAAATCGCATCCGCAGCGAGTCCGGTTTGTCTTTCCAGGCTGAATTTGGGGTGATGGCGCCGTTAAGCGATCCGGATGTGAAGTTAAGCGCCAGAGATCCCGGTGGCGTTCTGTCTACCAGTAATCTGGAGCGCGAACGTCGCGATATTGAAGACGATCTGGGCGGCGCGCAGGGGTTCTTGTCCGTGGCGGTGACGTATCAGTTCTAA	MADNSIVRLGATLILAAAYATSAQAADYSVGGMLGTQGVGVTAAKRTDWSLVDEDQLQLRFTFGGIDVDDVDDLELSGTKYKADFRTGTLTGGVDWYPFSGKYVDNIFFSGGLVYFDHDIKGTTKSGQSFNVGGAHVSSSDNVRLDAEIDQSSWAPYLSLGWGNRIRSESGLSFQAEFGVMAPLSDPDVKLSARDPGGVLSTSNLERERRDIEDDLGGAQGFLSVAVTYQF	MPMEQALFVRIARALAASLITLSAVAFAQEPKVDIPADQQAFVDICKPWDEWDKPAPPFEIYRDTYYVGTCGIAAILITDEEGHILIDSGTEAGADVVMANVAALGFDLKDVRYLLYSHEHFDHVGGMAKLQRATGALVVASKAAEPVLTSGEDSLADPQHGMHEPFEGVAVGRIMAAGDILELGGTTIRAIETPGHTPGAMSWWWQECKERCENIVYADSLSPISRDDYRFGDHPEYVAAYRAGLVALGREDCTVLLTPHPSHSRMIRRMQEGDLIENRQGTRPCARYAGQKLLDLETRLSNETLSEEDRAQ	73.80	gnl|BL_ORD_ID|3530|hsp_num:0	4599			372	684	
BGC0000260.1|Prodigiosin_23 # 27922 # 29526 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.576	BGC0000260.1|Prodigiosin_23 	27922	29526	-	Loose	800	194.512	ParS	35.76	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGATGTTGAGAACACTGCTGCGTTTGGTGATCGTCATTGTATTGCCGGTAGGGCTGCTGTTGACGGCGGAGTCTTACAACCCTGTTCATTACATTAAAAACCGCATTCTCCTCAATTACTTCGTTAACACCTATAACGGCACATTTTTCCTGATTGATCGCGATTTGACGGAGCGGCCGCAGAGCGCCTGGCAGGACAGAGTGGCGTCGTTGGATAACCATTTCGGCTATCGATTGCGGCTGACGCCTTTGGCGGAATTACTCACGCAAACGCAGTATGCCGATACCTTGCGAGAAGGCGGTTATGTCTATTCGGAGGCGGATACTGACGTGCTTTGGCGCAGGGTCGGCGACAGCGACTGGGTGGTTGAAATGGTGCTGGATGAAACGGATGACGAAGAGACGTTGCGCAGCGCCAAAGGCACACTGTTTCTGTTGGGCGACCTTTTTGCGGAAACGCCGGAAGCGCAATGGCTGCAGTTACTGACGCAATTGCAGGCGGAGTTTCGTTTTCCGCTGGATATGCTGGCGCTAACGGAGCTGGATATATCGGCTGACAAAAAAGAAGCGCTGATGACGAAAGGCTATGCGTGGACCAATACAGAGGACGATGAATCCTTGTTTTACTATCGTATTGGCGATAGCGATAAAGTCCTGACGGCGGGGCCGACGCCTTCGCCCGGCGGGGTGGCTCTCTCTTATTTGGTGACCGTGTTCACCGCCATGCTGTTAGCCACCTCCCTGGGGTTATTATCCTGGTTGACGCCTCTATGGCGTGATCTCAAACGCCTTGACCGTACGGCGTCGGAGTTTGGACAGGGCCGGCTGGAGCACCGCGTGACGCTGCGTAAAGGTTCTGTCGCCGCCCGTTTGGGGCAATCGTTCAACGCCATGGCGGACAGTATCCAGAAGCTGGTGCGTTCTCATCAACAGCTGACCAACGCCGTCGCCCATGATCTCCGCACTCCGTTGGCGCGCCTGCGTTTCGCGGTGGAAATTCTGGAGTCGGAAGACTGCACGGCGGAAGAGCAGGAGCGCTATCGCAAAAGCATCCACGCCAGCATTGATTCGCTGGATTACCTGATCAATCAATTACTCACCCATTCCCGATACAGCCGCGCCATCGACATCAATCATTTCAGCGAGATTGATCTGGCGTCCCTGGTGGAGGAAGAAGTGGACTTACATCAGCCGGAGCGCAGTGAGTTGGTGTGTGAGTTTGTCTGTGACGATAGTCTGCGCGGCGCCCGCATATGGGCGGACTCCCGCGCCATGGGTCGAGTGCTGCATAACCTGCTGGATAACGCCTCCCGCTATGCGCAATCCCGCGTACGGGTCAGCCTGCGTCGCGACGGCGCGCTCTGCCGCTTGCAGGTGGAGGATGACGGACCGGGCATTCCTCAGGAGGATCGGGAGACGATCCTGCAGCCCTTCGCCCAACTGGGCAACGTCGAACGCGCCTCATCCGGCGGACATGGCCTCGGGCTGGCGATCGTCAGCCAGATCGCGCAATGGCACCAGGGCGACGTCACCGTCGGCGACTCTTCATTGGGGGGCGCCGCGATTGAAATTTCCTGGCCGGCTCACGGGCCCACCGCCGGTTAG	MMLRTLLRLVIVIVLPVGLLLTAESYNPVHYIKNRILLNYFVNTYNGTFFLIDRDLTERPQSAWQDRVASLDNHFGYRLRLTPLAELLTQTQYADTLREGGYVYSEADTDVLWRRVGDSDWVVEMVLDETDDEETLRSAKGTLFLLGDLFAETPEAQWLQLLTQLQAEFRFPLDMLALTELDISADKKEALMTKGYAWTNTEDDESLFYYRIGDSDKVLTAGPTPSPGGVALSYLVTVFTAMLLATSLGLLSWLTPLWRDLKRLDRTASEFGQGRLEHRVTLRKGSVAARLGQSFNAMADSIQKLVRSHQQLTNAVAHDLRTPLARLRFAVEILESEDCTAEEQERYRKSIHASIDSLDYLINQLLTHSRYSRAIDINHFSEIDLASLVEEEVDLHQPERSELVCEFVCDDSLRGARIWADSRAMGRVLHNLLDNASRYAQSRVRVSLRRDGALCRLQVEDDGPGIPQEDRETILQPFAQLGNVERASSGGHGLGLAIVSQIAQWHQGDVTVGDSSLGGAAIEISWPAHGPTAG	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	124.77	gnl|BL_ORD_ID|2790|hsp_num:0	3805			267	1272	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000260.1|Prodigiosin_24 # 29529 # 30287 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.588	BGC0000260.1|Prodigiosin_24 	29529	30287	-	Loose	400	197.208	ParR	46.58	3005068	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGACACCCGTATTTTCGAACTGCGCTCACAATCATCGCTTGCTGCTGGTGGAGGATGACCAGGAGCTGGCTTCCTTGATTCAGGATTATCTGACCAAAAATGGTTTTCAGGTGGCGGTGGTCGCCAACGGGCTGGATGCGGTGCGGGAGATTCTGACGCAACGCCCGGCGCTGGTGATTCTGGACGTGATGCTGCCCGGGCTGTCGGGCATGGACGTATGTCGGCAGGCGCGGCTGGATTATAACGGGTTTATTCTCATGCTGACGGCGCTGGATGAGGATATGGACCAAATGCTGGGACTGGAGCTCGGCGCGGACGATTATATCGTGAAACCGGTGCAGCCGCGTTTATTGCTGAGTCGCATTCGCGCGCTGTTGCGACGGCTGGAGCACACAGGCCGCGGTGAGGGCGTCGCGGCGACGATTCAGGATAGCAGTGTGATCAGCGCCGGGGCATTGACGATCGACTTGCGCAACCGCGTGGTCAGACTGGGCGCGCGCTCGGTAGAGCTCACCACGGCGGAATTCGAGCTGTTATTGTTGCTGGCGAGATCACTGGGCGAAGTGGTCGATCGCGATTTTATCATTCAGGAATTACGCGGTTTTGATTACGACGGCTTGGACCGTTCCATAGACCGGCGCATCTCCCGTCTGCGCAAGAAGCTGCAGGACGGCGGGGCAGGGCAGGACATCATCAAAACGATTCGGGGCAAAGGCTATCAACTCTGCACTGACCCTGACCTGGCTGGGGGCCGTTGA	MTPVFSNCAHNHRLLLVEDDQELASLIQDYLTKNGFQVAVVANGLDAVREILTQRPALVILDVMLPGLSGMDVCRQARLDYNGFILMLTALDEDMDQMLGLELGADDYIVKPVQPRLLLSRIRALLRRLEHTGRGEGVAATIQDSSVISAGALTIDLRNRVVRLGARSVELTTAEFELLLLLARSLGEVVDRDFIIQELRGFDYDGLDRSIDRRISRLRKKLQDGGAGQDIIKTIRGKGYQLCTDPDLAGGR	MDCPTLSKVLLVEDDQKLARLIASFLSQHGFEVRQVHRGDAAFAAFLDFKPQVVVLDLMLPGQNGLQVCREIRRVANLPILILTAQEDDLDHILGLESGADDYVIKPIEPPVLLARLRALMRRHAPLPASPESLTFGKLNIDRRRREAELEGLGIELTTMEFELLWLLASQAGEILSRDEILNQIRGIGFDGLNRSVDVCISKLRNKLKDNPREPVRIKTVWGKGYLFNPLGWEL	107.23	gnl|BL_ORD_ID|2791|hsp_num:0	3806			3	678	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000260.1|Prodigiosin_27 # 31312 # 31842 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.520	BGC0000260.1|Prodigiosin_27 	31312	31842	+	Loose	400	24.6386	ErmW	35.48	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCATTGCCTTTCATTGCCGAAATAAGAATTTTTGGGTTCAACTACCCTCCCCGCAGTTGGTCATTTTGTAGTGGGCAAATCATCCCTATCGATGAAAACCAAGCCCTTTTCGCCTTGATAGGCTCCATTTACGGCGGCGACGCCAGGGTGACAATGGGGCTTCCCAATCTTCAAGGGCGCAGCCCTCTTCACACAGGTAAAGGCCCAGGCCTCACTGAGCGCCAGTTAGCAGATTATGGTGGATTGCCGGAGGTTGAGCTTGCAGCAGCACAGATACCTCCTCATACACACACCTTATCCGCAGCTAAGCAAGCAGGAACAACTTCAGAGCCCACTGGCCAGCTGTTCGCCTATCAGGCCGGGGACGTACAACCTGACTACAAACAGCCGCCACTTGGGGATCTGCAGGCGATGTCTCCAGGAATGTTGGCGTACGCAGGCCAGAGTTCAATGGTTGAAAATCGCCAGCCTTTTTTGGGACTTTCATTCTGCATAGCCTTAGATGGAATTTTTCCACCGCGAAACTAG	MSLPFIAEIRIFGFNYPPRSWSFCSGQIIPIDENQALFALIGSIYGGDARVTMGLPNLQGRSPLHTGKGPGLTERQLADYGGLPEVELAAAQIPPHTHTLSAAKQAGTTSEPTGQLFAYQAGDVQPDYKQPPLGDLQAMSPGMLAYAGQSSMVENRQPFLGLSFCIALDGIFPPRN	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	56.59	gnl|BL_ORD_ID|1572|hsp_num:0	1714			795	888	erythromycin; josamycin
BGC0000260.1|Prodigiosin_29 # 32478 # 33008 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.518	BGC0000260.1|Prodigiosin_29 	32478	33008	+	Loose	600	25.0238	emtA	40.62	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTCCGAACCATTTATCGCAGAAGTCCGCATATTCTCGTTTGATTTCCCTCCTGCAAGTTGGGCGTATTGTGACGGACAATTGTACGCTATAGGTCAAAACCCAGCTTTATTCTCTCTTATTGGAACCCTCTACGGAGGCGATGGAAGAACGACTATGGGCTTACCTAATCTTCAATGCCGAAGCCCGTTGCACGCTGGGACAGGCTTAGGCCTGACGCCTCGCCCTTTATCCAGCCTTGGAGGAACTCCCTACACAGTGCTTGATGAGATACAAATCCCCCCCCACACACATGCCCTCAAGGCAGTTGCTTCCCGCGGGACAACCCCTGAGCCGCAGAATCAGCTATTCGCCTATCAAGGGGGCGACCCTCAGCCTGATTACAAGCAATCTCCATTGGGCGATCTCGTGCCGATGCATCCTCAAATGCTGGCCAATACGGGCAATAGCGGTGCGCTCGATAATCGGCAACCCTTTTTGACTCTCTCTTTCTGTATCGCGCTTGACGGTATTTATCCACCAAGAAACTAA	MSEPFIAEVRIFSFDFPPASWAYCDGQLYAIGQNPALFSLIGTLYGGDGRTTMGLPNLQCRSPLHAGTGLGLTPRPLSSLGGTPYTVLDEIQIPPHTHALKAVASRGTTPEPQNQLFAYQGGDPQPDYKQSPLGDLVPMHPQMLANTGNSGALDNRQPFLTLSFCIALDGIYPPRN	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	51.61	gnl|BL_ORD_ID|2212|hsp_num:0	3368			141	237	evernimicin
BGC0000260.1|Prodigiosin_31 # 33468 # 33602 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.526	BGC0000260.1|Prodigiosin_31 	33468	33602	-	Loose	500	23.483	OXA-728	43.48	3005933	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGTGGGCCGCTCAGAGAAGGTACAACCGCTACTTCAGCATAGACCCGAACCTTTTGATTTATCAAGTTAAGTCCGTCCGCGCAGGGCTTTCTCTAACGAGGAGTGTATTGCGTCGGCCCGGCTTTCATTAG	MMWAAQRRYNRYFSIDPNLLIYQVKSVRAGLSLTRSVLRRPGFH	MKKTLFFAVSAWMLSACSGGIMMSGDNQKKSPFISSKTEDSRIQQIPQLFNEAGTQAVFVTFDGTVLKRYGNDLTRAQTEYIPASTFKMLNALIGLQHGKATATEVFKWNGEKRSFPAWEKDMTLAQAMQASAVPVYQELARRIGLELMQQEVRRAGFGNADIGKQVDNFWLVGPLKVTPEQEARFAYGLATEQLGFDTAVQKQVKDMLYIEGRGDVKLYAKSGWGMDVNPQVGWYTGWVDDGHGKVTAFALNMQMEQGDDVGERKQLTLDVLDKLGVFFYLH	15.55	gnl|BL_ORD_ID|3968|hsp_num:0	5038			405	474	cloxacillin; oxacillin; cefalotin
BGC0000260.1|Prodigiosin_32 # 33646 # 33930 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.498	BGC0000260.1|Prodigiosin_32 	33646	33930	+	Loose	400	23.8682	tetB(P)	36.36	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGAAGCCATCACAAGGGACGATGTGGTCATGCATAGTGACAAACAGGTTTCCTGCTCTGTCGATCAAGGCGTTGTCGTCATGCACGTCAATGCCGGTGAATTCTACGACTTAAACCATTCCGCGTCCGATGTCTGGAGGCTATTGGACTCTCCTACAAAAGTGTCGACACTGTGCGATCGCCTTCGCGAGAAGTATAACGTCGACTCCGAGCGCTGCGAAAAAGATGTACTCAACCTGCTCAATCGTTTGCAGGAAAAAGGCGTCATCGAAGCGCAAAAATGA	MEAITRDDVVMHSDKQVSCSVDQGVVVMHVNAGEFYDLNHSASDVWRLLDSPTKVSTLCDRLREKYNVDSERCEKDVLNLLNRLQEKGVIEAQK	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	14.42	gnl|BL_ORD_ID|737|hsp_num:0	804			852	948	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000260.1|Prodigiosin_33 # 34161 # 34661 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.461	BGC0000260.1|Prodigiosin_33 	34161	34661	-	Loose	500	24.6386	OXA-726	50.0	3005931	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGGGGCTCTTCTATTATCAAGGTTGTGATCTTTTGAGTGACGATATTTGTCCATTATCGTTAGAGGGGAGCGAGGTTAGTTTATGCCCTGGTTTCCCAAGACTTAAGCTATCATCGGAAATATTGTTGACAATGGGGGAAACGCCGGAGAATCATCCTCGTCTACCCTTTAAAACCAGGGTCAAACACTGCTATCCGGCGAGTCGTAACTTCTCTCTAAAAAAAGCTTTTGTACAAAGTGTCTATATCTTGACGGAAGGAAGGGAGCTTTCATTGCAGAAGCTAACGCCACAAGAGGCGATAGCAGGGTTATTTGAACACTGCTTCAGAAAGGTGTTTCTGGTCTCGCTTGAGCAGCGGAAAATGATGCTGAATGCATGCGCGACGCTTGCAGGCGTTACGTCTGTTTATTCTTTGCAGCGCCCTAAATTGATGTCGGAAGCAATAAGTATCGTGGATATGCTTGCAGCGCGGGAATTAGAGGCGTCTACAGCTTGA	MAGLFYYQGCDLLSDDICPLSLEGSEVSLCPGFPRLKLSSEILLTMGETPENHPRLPFKTRVKHCYPASRNFSLKKAFVQSVYILTEGRELSLQKLTPQEAIAGLFEHCFRKVFLVSLEQRKMMLNACATLAGVTSVYSLQRPKLMSEAISIVDMLAARELEASTA	MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAKLKTL	62.88	gnl|BL_ORD_ID|3966|hsp_num:0	5036			207	267	cloxacillin; oxacillin; cefalotin
